PRESCRIBING · PART D · 2024
Total Rx claims
1,820
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
48
Brand share
32.5%
Top prescribed drugs
Gabapentin197 claims
Levetiracetam150 claims
Sertraline Hcl85 claims
Carbidopa/Levodopa78 claims
Pregabalin77 claims
QUALITY · MIPS · 2024
Final MIPS score
84.6
Quality
68.8
Cost
72.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.41%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$789
Payment records
49
By payment type
Food and Beverage$789
Top paying entities
Food and Beverage$789
CROSS-REFERENCE